National Institutes of Health
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing December 23, 2027.
Overview
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product…